TESSARI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.330
AS - Asia 6.715
EU - Europa 3.844
AF - Africa 1.094
SA - Sud America 1.013
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 105
Totale 27.229
Nazione #
US - Stati Uniti d'America 13.731
SG - Singapore 2.241
IT - Italia 1.530
CN - Cina 1.210
HK - Hong Kong 743
VN - Vietnam 707
BR - Brasile 608
BD - Bangladesh 288
FR - Francia 281
FI - Finlandia 265
DE - Germania 252
IN - India 218
SE - Svezia 161
GB - Regno Unito 152
UA - Ucraina 135
IQ - Iraq 132
NL - Olanda 100
TR - Turchia 100
PL - Polonia 98
RU - Federazione Russa 97
AR - Argentina 90
CA - Canada 89
JP - Giappone 68
PH - Filippine 68
PK - Pakistan 68
ID - Indonesia 63
ZA - Sudafrica 56
MX - Messico 55
SA - Arabia Saudita 55
EC - Ecuador 53
UZ - Uzbekistan 51
BJ - Benin 47
IE - Irlanda 47
CO - Colombia 44
MY - Malesia 44
AO - Angola 43
ES - Italia 41
KE - Kenya 40
MA - Marocco 40
KG - Kirghizistan 39
BE - Belgio 37
CL - Cile 37
VE - Venezuela 37
AL - Albania 36
CW - ???statistics.table.value.countryCode.CW??? 36
GT - Guatemala 36
JO - Giordania 36
GR - Grecia 35
PS - Palestinian Territory 35
UG - Uganda 35
AZ - Azerbaigian 34
BG - Bulgaria 34
NG - Nigeria 34
PE - Perù 34
PT - Portogallo 34
TH - Thailandia 34
CZ - Repubblica Ceca 33
DZ - Algeria 33
HN - Honduras 33
JM - Giamaica 32
TN - Tunisia 32
CR - Costa Rica 31
PY - Paraguay 31
AU - Australia 30
BY - Bielorussia 30
CV - Capo Verde 30
ET - Etiopia 30
NO - Norvegia 30
AM - Armenia 29
IL - Israele 29
MN - Mongolia 29
RO - Romania 29
UY - Uruguay 29
AE - Emirati Arabi Uniti 28
AT - Austria 28
CH - Svizzera 28
GA - Gabon 28
LA - Repubblica Popolare Democratica del Laos 28
LV - Lettonia 28
LY - Libia 28
MD - Moldavia 28
NP - Nepal 28
DO - Repubblica Dominicana 27
EG - Egitto 27
GH - Ghana 27
KH - Cambogia 27
KZ - Kazakistan 27
LB - Libano 27
MZ - Mozambico 27
NI - Nicaragua 27
PA - Panama 27
ZW - Zimbabwe 27
CD - Congo 26
CG - Congo 26
IR - Iran 26
ME - Montenegro 26
MR - Mauritania 26
PR - Porto Rico 26
GF - Guiana Francese 25
KR - Corea 25
Totale 25.962
Città #
Ashburn 1.622
Fairfield 1.596
Singapore 1.422
Woodbridge 1.224
San Jose 1.169
Chandler 727
Houston 680
Hong Kong 675
Seattle 633
Wilmington 573
Ann Arbor 556
Cambridge 554
Jacksonville 450
Santa Clara 277
Los Angeles 247
Princeton 246
Boardman 216
Beijing 211
Ho Chi Minh City 203
San Diego 162
Hanoi 151
Milan 137
Lauterbourg 135
New York 134
Roxbury 134
Rome 113
Helsinki 102
Nanjing 100
Padova 100
Des Moines 87
Dong Ket 85
Council Bluffs 84
Medford 83
Munich 70
Dallas 65
Bytom 60
Guangzhou 59
Tashkent 50
Buffalo 49
São Paulo 49
Chicago 46
Baghdad 45
Cotonou 45
Naples 45
Shenyang 40
Orem 39
Turin 39
Tianjin 35
Amman 34
Atlanta 34
Nairobi 33
Bishkek 32
Dublin 32
Kampala 32
Luanda 32
Baku 30
Brooklyn 30
London 30
Nanchang 30
Tokyo 29
Florence 28
Haiphong 28
Hebei 28
Libreville 28
Willemstad 28
Praia 27
Ulan Bator 27
Bologna 26
Guatemala City 26
Phnom Penh 26
Verona 26
Vientiane 26
Warsaw 26
Chennai 25
Jinan 25
Managua 25
Norwalk 25
Rio de Janeiro 25
Toronto 25
Addis Ababa 24
Harare 24
Istanbul 24
Abidjan 23
Accra 23
Bari 23
Changsha 23
Da Nang 23
Jiaxing 23
Nouakchott 23
Panama City 23
Podgorica 23
Riga 23
Turku 23
Dushanbe 22
Frankfurt am Main 22
Hefei 22
Johannesburg 22
Lahore 22
Lusaka 22
Maputo 22
Totale 16.981
Nome #
Metabolismo Proteico 1.117
Effect of Reversal of the Whey protein to casein ratio of cow milk on insulin and incretin responses in humans 510
Aminoacidi essenziali: principali determinanti della nutrizione e dell'impronta ambientale 381
Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin. 328
Effects of Low-Protein, and Supplemented Very Low-Protein Diets, on Muscle Protein Turnover in Patients With CKD. 318
A Multifunctional Bread Rich in Beta Glucans and Low in Starch Improves Metabolic Control in Type 2 Diabetes: A Controlled Trial 297
Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy 293
Effect of liver cirrhosis on phenylalanine and tyrosine metabolism 282
Lumican is overexpressed in lung adenocarcinoma pleural effusions. 282
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy 267
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 266
Essential amino acids: master regulators of nutrition and environmental footprint? 265
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 263
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 257
Middle age is not associated with altered fibrinogen concentration and production in males. 257
No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. 257
Kinetics of albumin homocysteinylation measured with matrix-assisted laser/desorption ionization mass spectrometry versus with a radioactive tracer. 255
Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. 251
Delta2D and Proteomweaver: Performance evaluation of two different approaches for 2-DE analysis 250
Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man. 247
Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach. 246
Effects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings. 245
A rapid method to determine plasma homocysteine concentration and enrichment by gas chromatography/mass spectrometry. 244
Improved instrumentation for large-size two-dimensional protein maps 240
Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin 232
Caldesmon over-expression in type 1 diabetic nephropathy 231
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study 228
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy 228
Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus 227
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 226
Decreased Homocysteine Trans-Sulfuration in Hypertension With Hyperhomocysteinemia: Relationship With Insulin Resistance 224
The inter- and intra-operator variability in manual spot segmentation and its effect on spot quantitation in two-dimensional electrophoresis analysis. 221
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population. 220
Effect of reversal of whey-protein to casein ratio of cow milk, on insulin, incretin and amino acid responses in humans 220
Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects 219
Dose-response curves of effects of insulin on leucine kinetics in humans. 218
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 213
High confidence and sensitivity four-dimensional fractionation for human plasma proteome analysis. 213
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. 213
Effects of CK2 inhibition in cultured fibroblasts from Type 1 Diabetic patients with or without nephropathy 213
SDS-PAGE and two-dimensional maps in a radial gel format. 212
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 211
Insulin on methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models 208
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 207
The Effects of Rosiglitazone and High Glucose on Protein Expression in Endothelial Cells 207
The contribution of muscle, kidney, and splanchnic tissues to leucine transamination in humans. 207
Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. 203
VLDL-Apo B 100 fractional synthesis rate (FSR) is decreased in type 2 diabetes mellitus patients with diabetic nephropathy and hypertriglyceridaemia: possible defect in VLDL-Apo B 100 removal 203
Sample loading influences studies comparing isoelectric focusing vs. strong cation exchange peptide fractionation 202
Roles of insulin, age, and asymmetric dimethylarginine, on nitric oxide synthesis in vivo. 201
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 201
Are there dietary requirements for dispensable amino acids and if so, how do we assess requirements? 199
Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides. 195
Leucine Transamination Is Lower in Middle-Aged Compared with Younger Adults. 195
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. PMID: 16186400 194
Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes 194
Leucine and phenylalanine kinetics during mixed meal ingestion: a multiple tracer approach. 193
Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes 185
Neither Incretin or Amino Acid Responses, nor Casein Content, Account for the Equal Insulin Response Following Iso-Lactose Loads of Natural Human and Cow Milk in Healthy Young Adults 185
La Dieta Sostenibile 183
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 181
Reduced in vivo biological activity of in vitro glycosylated insulin. 181
La guerra delle etichette tra Italia e Europa. Cosa dice la Scienza? 181
Insulin resistance of amino acid and protein metabolism in type 2 diabetes 180
A fast high-performance liquid chromatographic method for the measurement of plasma concentration and specific activity of phenylalanine. 180
Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy 179
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 179
Rapid, simple and effective technical procedure for the regeneration of IgG and HSA affinity columns for proteomic analysis. 179
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 178
Compartmental model of leucine kinetics in humans 178
A High-Fiber Diet Decreases Postabsorptive Protein Turnover but Does Not Alter Insulin Sensitivity in Men with Type 1 Diabetes Mellitus. 176
Polar electrophoresis: shape of two-dimensional maps is as important as size. 173
Nitric oxide in the normal kidney and in patients with diabetic nephropathy. 173
Evidence for acute stimulation of fibrinogen production by glucagon in humans. 171
La Nutrizione Artificiale (NA) nel diabete mellito. Parte prima: Fisiologia del metabolismo dei substrati in corso di NA ed effetti del diabete 170
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 169
Effects of insulin and amino acid infusion on leucine and phenylalanine kinetics in type 1 diabetes. 168
Pros and cons of peptide isolectric focusing in shotgun proteomics 167
Environmental footprint of vegetal and animal based foods in relation to the nutritional requirements of the human body 166
Ketoacidosis in diabetic subjects treated with inhibitors of Na(+)-glucose co-transporters type-2: New mechanisms? 164
Phenylalanine hydroxylation across the kidney in humans 163
Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans. 160
Alpha cell autoantibodies: immunological and metabolic follow-up study. 160
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 156
Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. 156
Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes. 156
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 156
A model of skeletal muscle leucine kinetics across the human forearm 155
Hyperglucagonemia stimulates phenylalanine oxidation in man. 154
Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. 152
Kidney, splanchnic and leg protein turnover in humans: insight from leucine and phenylalanine kinetics. 150
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 150
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 150
Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon. 150
Proteomica e Diabete 150
Operator- and software-related post-experimental variability and source of error in 2-DE analysis. 149
Mechanisms of post-prandial protein accretion in human skeletal muscle: insight from leucine and phenylalanine forearm kinetics. 148
Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. 148
Effects of insulin on whole-body and regional amino acid metabolism. 146
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 146
Totale 21.697
Categoria #
all - tutte 74.066
article - articoli 68.178
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 1.486
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.626
Totale 146.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.827 0 214 223 138 69 106 76 192 89 48 210 462
2022/20231.437 323 161 31 162 215 158 6 109 174 22 55 21
2023/20241.271 42 98 113 53 75 141 68 128 96 144 164 149
2024/20253.038 50 245 181 182 433 99 117 230 183 108 507 703
2025/202611.766 487 942 1.463 1.754 1.168 567 1.510 1.118 1.221 717 459 360
2026/2027946 525 421 0 0 0 0 0 0 0 0 0 0
Totale 27.229